Is there a need to reconsider the use of metformin in COVID-19 patients with type 2 diabetes mellitus?

INTRODUCTION: Diabetes has been linked with poorer outcomes in coronavirus disease (COVID-19) patients. However, the question to whether continue or withdraw metformin therapy in COVID-19 patients with type 2 diabetes mellitus remains contentious. This study aims to investigate the association betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazarus, Gilbert, Suhardi, Indira P., Wiyarta, Elvan, Rasyidah, Rufiah A., Barliana, Julie D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Short Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922709/
https://www.ncbi.nlm.nih.gov/pubmed/33679040
http://dx.doi.org/10.1007/s13410-021-00924-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922709/
https://www.ncbi.nlm.nih.gov/pubmed/33679040
http://dx.doi.org/10.1007/s13410-021-00924-w

Ejemplares similares